(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione
-
(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione
structure -
-
CAS No:
88660-47-3
-
Formula:
C32H43N5O5
-
Chemical Name:
(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione
-
Synonyms:
Ergotaman-3′,6′,18-trione,9,10-dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]-,(5′α,10α)-;Ergotaman-3′,6′,18-trione,9,10-dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-,[5′α(R),10α]-;(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione;Epicriptine;(R)-Dihydro-β-ergocryptine;[5′(R)]-Dihydro-β-ergocryptine;(R)-9,10-Dihydro-β-ergocryptine
- Categories:
-
CAS No:
Description
Epicriptine is a peptide ergot alkaloid.|Epicriptine is also known as beta-dihydroergocryptine presents a molecular formula of 9,10 alpha-dihydro-13'-epi-b-ergocryptine. Together with the alpha-dihydroergocryptine, it represents one-third of the ergoloid mesylate mixture. Epicriptine differs from the alpha form on the position of one methyl group. To know more about the mixture please visit [DB01049]
(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione Basic Attributes
577.722
577.71
5M64643B5U
Toxicity
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Drug Information
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Epicriptine effect is mainly due to the agonistic activity on dopamine receptor. This activity is categorized as part of the ergoline class which is defined as a producer of a vasoconstrictive effect. Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
9,10-dihydro-12'-hydroxy-2'-isopropyl-5'-(1-methylpropyl)ergotaman-3',6',18-trione
Computed Properties
Molecular Weight:577.7
XLogP3:3.1
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:5
Exact Mass:577.32641949
Monoisotopic Mass:577.32641949
Topological Polar Surface Area:118
Heavy Atom Count:42
Complexity:1130
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Latest News on (5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione
Learn More Other Chemicals
-
3-(3-CHLOROPROPYLCARBAMOYL)BENZENEBORONIC ACID
874288-10-5
-
3-Pyridinecarboxylic acid, 2,6-dichloro-, ethyl ester
58584-86-4
-
(+)-Mesembrenone
468-54-2
-
1,5-Methano-1H-3-benzazepine, 2,3,4,5-tetrahydro-, hydrochloride (1:1) Formula
230615-52-8
-
(4-acetyloxyphenyl)-(4-acetyloxyphenyl)imino-oxidoazanium Formula
79030-44-7
-
1-(4-Methoxy-phenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde Formula
347331-30-0
-
2,2'-DIAMINODIPHENYL SULFIDE Structure
5873-51-8
-
AC-ARG-PHE-MET-TRP-MET-ARG-NH2 Structure
152274-65-2
-
What is 1,1-Dimethylethyl 2-bromo-2-methylpropanoate
23877-12-5
-
What is 1,3-Dichloro-2,4-difluorobenzene
36556-37-3
(5′α,10α)-9,10-Dihydro-12′-hydroxy-2′-(1-methylethyl)-5′-[(1R)-1-methylpropyl]ergotaman-3′,6′,18-trione
SDSRequest for Quotation